Basic Information
Basic information for FTX-264-11aa-2
Peptide Name FTX-264-11aa-2
Genome Position chrX:74203778-74203810[-]
Species Human
Peptide Sequence MPRLTDVRRLS
Peptide Length 11
Unique No (FTX-202-11aa-2,FTX-210-11aa-4,FTX-218-11aa-1,FTX-223-11aa-2,FTX-224-11aa-1,FTX-228-11aa-2,FTX-229-11aa-1,FTX-231-11aa-2,FTX-233-11aa-2,FTX-236-11aa-3,FTX-238-11aa-2,FTX-241-11aa-1,FTX-245-11aa-1,FTX-257-11aa-3,FTX-261-11aa-2,FTX-265-11aa-3,FTX-266-11aa-3,FTX-268-11aa-1)
Grand Average of Hydropathicity -0.5818
Relative Molecular Mass 1523.78
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000665069;FTX-264
Transcript Length 1958
Coding Ability 0.6001
DNA Sequence Corresponding to Peptide ATGCCTCGGCTGACTGACGTGAGAAGATTGTCA
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :